Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
about
Stathmin is dispensable for tumor onset in miceThe Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 PhosphorylationStathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancerStathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developmentsERG induces taxane resistance in castration-resistant prostate cancerStathmin overexpression is associated with growth, invasion and metastasis of lung adenocarcinomaProteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer.Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.Movers and shakers: cell cytoskeleton in cancer metastasis.RETRACTED: STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells.The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancerStathmin mediates hepatocyte resistance to death from oxidative stress by down regulating JNK.An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cellsStathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinomaCombined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast CancerA delay prior to mitotic entry triggers caspase 8-dependent cell death in p53-deficient Hela and HCT-116 cells.Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.Overexpression of SCLIP promotes growth and motility in glioblastoma cellsp27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.PIWIL1 destabilizes microtubule by suppressing phosphorylation at Ser16 and RLIM-mediated degradation of Stathmin1.Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cellsStathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma.Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer.Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancerStathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.Stathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma.Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivoMAP/microtubule affinity-regulating kinases, microtubule dynamics, and spermatogenesisLentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo.Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.cAMP-dependent protein kinase and c-Jun N-terminal kinase mediate stathmin phosphorylation for the maintenance of interphase microtubules during osmotic stress.An underlying prognosis predictor of hepatocellular carcinoma: Oncoprotein 18.RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasisp27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis.Small Rho GTPases in the control of cell shape and mobility.Stathmin 1 in normal and malignant hematopoiesis.
P2860
Q21134036-96686240-508E-4B1B-A40D-1A618B699F45Q27312678-B0777E5D-AA91-4E03-86C8-9269781A3868Q27852937-2D6AB183-E3BE-4839-829E-33C0F9A1CC6EQ28079927-86E19ED0-BFD4-4441-AD2B-73A14DC848D8Q30602046-7B0D7B46-5B00-40CB-B567-F927DBCAE0B1Q33688496-7FA38D92-9FC1-4AD2-B511-4A97E1F4C6A5Q34016179-FA2239F4-E9A0-46D1-9B59-9A3948D94ACDQ34608899-4411C1DD-A45A-45CC-AA08-B2799D1125AAQ34617881-39663028-92D1-4BCF-9EE9-621D0233D881Q34914057-4CFFA91E-722D-4C64-AF34-E9A58ECD5607Q35085500-EC509DBF-F98E-4384-80C0-553C7E3CFB19Q35214846-7277736D-2BD3-444D-9F4F-18984BA8882AQ35303879-7BB3A243-F105-4173-BA89-F80B7E077A8EQ35632172-0F88E453-094F-4D29-9F8F-C6E421340E28Q35924139-ED8DDD92-AFCE-4D22-8F28-850745A796A5Q36103306-6273640E-F201-4C5B-B2AE-0976388DEA4BQ36103894-B14DF78C-195E-46DF-8D48-173CCD7D57ABQ36180709-8ABDAE83-FE3D-4EE3-876C-45BA5A70712EQ36182287-906B02DA-E0FC-4172-8283-818F3FFC8FCAQ36215787-9F8BD8E1-8B6C-43BE-B7A4-3C1AF50E7A66Q36300446-7C4D759B-3A75-4020-9AB0-55C73EE5A5C2Q36355929-C5857334-1514-4D5B-94C1-4898FEBA745FQ36413910-53AFB7F2-C16F-4AE9-BD48-186D13983852Q36557368-B1E83C60-D0FD-4DB5-8518-D94F21D299E7Q36679284-C802E950-2DC2-48F2-877F-DB7B9FBCE8B6Q36756699-E4259E79-6238-40CF-AB22-33CBB1512BF1Q36774388-569CDDFC-63FC-43ED-8925-FC5C1645E2D0Q36870100-660286A5-6C35-4107-9E4F-101D11490227Q36931508-22A5A092-1EC3-41CF-8069-AAC0B41D2A5BQ37044488-DC31CDEF-A4A8-47CF-AB61-98422C742E3CQ37244832-BC487D34-0208-4261-86A1-C9977C737DEEQ37359873-E58669D0-E376-48C0-9EF7-4BFE3587CF19Q37387807-0B14BE0B-06A3-4581-8D6F-10C695357B96Q37511735-F46684F2-B2A1-4CDA-94FA-65631BB9592FQ37565193-68818246-02B7-4AE3-ADA0-26D2782EAF59Q37579739-84CEC0FD-0529-4088-8253-F402127A88CAQ37662085-B2CC35FC-4BAB-4D52-AE85-EADADF6E93E3Q37694739-094B0283-0C85-42DB-BF57-127FD7BC12B9Q38166254-E8ABDF99-3987-4721-B5AD-81A423317B6FQ38199283-DE34105B-20DD-4F63-B004-900A584DA508
P2860
Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
@en
Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
@nl
type
label
Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
@en
Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
@nl
prefLabel
Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
@en
Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
@nl
P2860
P1476
Stathmin: a protein with many tasks. New biomarker and potential target in cancer.
@en
P2860
P304
P356
10.1517/14728222.2011.620951
P407
P577
2011-10-07T00:00:00Z